Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Protocol for MAAESTRO: Electronic Monitoring and Improvement of Adherence to Direct Oral Anticoagulant Treatment-A Randomized Crossover Study of an Educational and Reminder-Based Intervention in Ischemic Stroke Patients Under Polypharmacy
JournalItem (Reviews, Editorials, Rezensionen, Urteilsanmerkungen etc. in einer wissenschaftlichen Zeitschrift)
 
ID 4526314
Author(s) Polymeris, Alexandros A.; Albert, Valerie; Hersberger, Kurt E.; Engelter, Stefan T.; Schaedelin, Sabine; Arnet, Isabelle; Lyrer, Philippe A.
Author(s) at UniBasel Arnet, Isabelle
Polymeris, Alexandros
Albert, Valerie
Hersberger, Kurt
Engelter, Stefan
Lyrer, Philippe A.
Schädelin, Sabine
Year 2018
Title Protocol for MAAESTRO: Electronic Monitoring and Improvement of Adherence to Direct Oral Anticoagulant Treatment-A Randomized Crossover Study of an Educational and Reminder-Based Intervention in Ischemic Stroke Patients Under Polypharmacy
Journal Frontiers in Neurology
Volume 9
Pages 1134
Keywords adherence; adherence-improving intervention; direct oral anticoagulants; electronic monitoring; ischemic stroke; multi-compartment compliance aid; polypharmacy
Abstract Background: Non-adherence to direct oral anticoagulants (DOACs) remains a matter of concern, especially for patients with a recent stroke. However, data on electronically monitored adherence and adherence-improving interventions are scarce. Aims: We aim to use electronic monitoring in DOAC-treated stroke patients to (i) evaluate the effect of an educational, reminder-based adherence-improving intervention, (ii) investigate predictors of non-adherence, (iii) identify reliable self-report measures of adherence, and (iv) explore the association of non-adherence with clinical outcomes. Methods: Single-center, randomized, crossover, open-label study. Adherence to DOACs of polymedicated patients self-administering their medication will be monitored electronically throughout the 12-month-long study following hospitalization for ischemic stroke. After a 6-month observational phase, patients will receive pharmaceutical counseling with feedback on their intake history and be given a multi-compartment pillbox for the subsequent 6-month interventional phase. The pillbox will provide intake reminders either during the first or the last three interventional-phase months. Patients will be randomly allocated to reminders-first or reminders-last. Study outcomes: Primary: non-optimal timing adherence; Secondary: non-optimal taking adherence; timing adherence; taking adherence; self-reported adherence; clinical outcomes including ischemic and hemorrhagic events; patient-reported device usability and satisfaction. Sample size estimates: A sample of 130 patients provides 90% power to show a 20% improvement of the primary adherence outcome with intake reminders. Discussion: MAAESTRO will investigate various aspects of non-adherence and evaluate the effect of an adherence-improving intervention in DOAC-treated patients with a recent stroke using electronic monitoring. Clinical Trial Registration: ClinicalTrials.gov identifier: NCT03344146, Swiss National Clinical Trials Portal SNCTP000002410.
Publisher FRONTIERS MEDIA SA
ISSN/ISBN 1664-2295
edoc-URL https://edoc.unibas.ch/74559/
Full Text on edoc No
Digital Object Identifier DOI 10.3389/fneur.2018.01134
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/30622509
ISI-Number WOS:000454099000001
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.391 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
14/04/2024